93OPhase 2 study of pembrolizumab for metastatic triple-negative breast cancer (mTNBC): Japanese subgroup results of KEYNOTE 086M Hattori,Kenji Tamura,Hirofumi Mukai,Y Miyoshi,Norikazu Masuda,E Suzuki,H Ishiguro,Shoichiro Ohtani,F Hara, T Shimamoto,K Yamamoto,Y Ding,G Aktan,V Karantza,Hiroji IwataAnnals of Oncology(2017)引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要